Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistence.
L'Huillier AG, Pagano S, Baggio S, Meyer B, Andrey DO, Nehme M, Guessous I, Eberhardt CS, Huttner A, Posfay-Barbe KM, Yerly S, Siegrist CA, Kaiser L, Vuilleumier N.
L'Huillier AG, et al.
Eur J Clin Invest. 2022 Oct;52(10):e13818. doi: 10.1111/eci.13818. Epub 2022 Jun 2.
Eur J Clin Invest. 2022.
PMID: 35598178
Free PMC article.